Cargando…
Immunogenicity and Safety of a Chemically Synthesized Divalent Group A Streptococcal Vaccine
BACKGROUND: Group A streptococcus (GAS) infections and poststreptococcal sequelae remain a health problem worldwide, which necessitates searching for an effective vaccine, while no licensed GAS vaccine is available. We have developed a divalent peptide vaccine composed of 84 amino acids to cover the...
Autores principales: | Wu, Yongxiang, Li, Suhua, Luo, Yanting, Zhao, Yunyue, Wang, Jiarui, Dong, Ruimin, Xie, Xujing, Zhu, Jieming, Liu, Jinlai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5851172/ https://www.ncbi.nlm.nih.gov/pubmed/29682128 http://dx.doi.org/10.1155/2018/4702152 |
Ejemplares similares
-
Predictive value of P wave terminal force in lead V1 for atrial fibrillation: A meta‐analysis
por: Huang, Zhuoshan, et al.
Publicado: (2020) -
Type-specific immunogenicity of a chemically synthesized peptide fragment of type 5 streptococcal M protein
Publicado: (1983) -
The feasibility and safety of a simple method for coronary sinus blood sampling during catheter ablation of arrhythmias
por: Zheng, Zhenda, et al.
Publicado: (2022) -
Atrial fibrillation increases inpatient and 4-year all-cause mortality in critically ill patients with liver cirrhosis
por: Luo, Yanting, et al.
Publicado: (2021) -
Serum lipoprotein(a) and risk of periprocedural myocardial injury in patients undergoing percutaneous coronary intervention
por: Huang, Zhuoshan, et al.
Publicado: (2020)